Skip to main content

Table 6 Changes in BCVA from baseline to 1 year after surgery

From: The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study

BCVA (logMAR)

IVC group (mean ± SD)

Control group (mean ± SD)

P value

Preoperative

2.02 ± 0.8

1.62 ± 0.69

0.18

day1

2.04 ± 1.02

1.89 ± 1.02

0.70

1 week

1.09 ± 0.66

1.06 ± 0.47

0.89

1 month

0.75 ± 0.6

0.63 ± 0.36

0.55

3 months

0.79 ± 0.82

0.74 ± 0.54

0.86

6 months

0.67 ± 0.64

0.74 ± 0.53

0.78

1 year

0.56 ± 0.52

0.42 ± 0.37

0.43

  1. IVC Intraoperative intravitreal conbercept group
  2. BCVA Best corrected visual acuity
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us